Awards & Advancement

Clinipace Worldwide Co-founder & CEO Jeff Williams to resign as CEO

Wednesday, October 18, 2017

Jeff Williams, Co-founder, President and CEO of Clinipace Worldwide, a global full-service CRO that he founded 14 years ago, has elected to move into an expanded advisory role with the company’s Board of Directors. He will be handing over his responsibilities to Jason Monteleone, who will assume the role of Chief Executive Officer. Williams will remain a Director and will focus on strategic initiatives on behalf of the Board of Directors. 

[Read More]

Canadian biotech industry names top performers

Tuesday, October 17, 2017

BIOTECanada announces winners of the 2017 Gold Leaf Awards, which recognize biotechnology excellence. Launched in 2001, the Gold Leaf awards are given annually to recognize both companies and individuals who have made significant contributions to the biotech industry in Canada. The Awards’ importance to the recipients and the industry more broadly has grown significantly over the years.

[Read More]

INC Research/inVentiv Health honored with SRCS Eagle Award

Wednesday, October 11, 2017

INC Research/inVentiv Health, the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract Commercial Organization), announced that it was awarded the 2017 Society for Clinical Research Sites (SCRS) Eagle Award in the CRO category during the SCRS Annual Global Site Solutions Summit held October 6-8 in Boca Raton, Florida. The award recognizes the CRO that best exemplifies outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.

[Read More]

Algorics announce Dr. Malcolm Burgess as new advisory board member

Tuesday, October 10, 2017

Algorics, a provider of clinical analytics solutions and software for the global life sciences industry, announced the appointment of Dr. Malcolm Burgess to the Advisory Board of Algorics. Dr. Burgess will help to continue to shape and guide the Algorics Risk Based Monitoring (RBM) strategy working closely with the leadership team.

[Read More]

NIH Director’s high-risk research awards announced for 2017

Tuesday, October 10, 2017

The NIH’s High-Risk, High-Reward Research program, part of the NIH Common Fund, funded 86 awards to exceptionally creative scientists proposing to use highly innovative approaches to tackle major challenges in biomedical research. The program supports high-risk ideas with high-impact potential, such as recording the history of an individual cell in its DNA for future playback; understanding how bacteria in the microbiome can share anti-drug-resistance genes among themselves; resetting the immune system to allow universal organ transplants; and reimagining clinical trials to make them more personalized and more effective.

[Read More]

Research!America announces 2018 Advocacy Awards Honorees

Friday, October 6, 2017

A former congressional leader who was instrumental in doubling the NIH budget, the head of a global research center aimed at reducing the burden of disease, two long-time mental health advocates dedicated to accelerating research, a rare disease organization committed to biotech innovation, and a world-renowned vaccine researcher are among those who will be honored at Research!America’s 22nd annual Advocacy Awards on Wednesday, March 14, 2018, in Washington, D.C. The honorees for the Isadore Rosenfeld Award for Impact on Public Opinion and the Edwin C. Whitehead Award for Medical Research Advocacy will be announced in the coming weeks.

[Read More]